Landscapes / Companies

Beijing Biotech not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
31 in Phase 2
2 in Phase 1
Next date
Dual-target CAR-NK cells, Phase 1/2 trial completes
Drugs
33
in active trials
Trials
32 active
32 since 2021

Drugs33

DrugHow it worksPartnerStageNext dateDetails
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes

See all 33 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Beijing Biotech

Following is part of Solo: you see every change to Beijing Biotech the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in